Inhibitors
Deregulated kinase activity is a frequent cause of disease, in particular cancer, wherein kinases regulate many aspects that control cell growth, movement and death. Drugs that inhibit specific kinases are being developed to treat several diseases, and some are currently in clinical use, including Gleevec (imatinib) and Iressa (gefitinib).
- Anthra(1,9-cd)pyrazol-6(2H)-one
- Staurosporine
Read more about this topic: Protein Kinase